44, Rochester Clinical Research Inc.

Rochester, New York 14609

0 studies enrolling now · 1 studies all time

What they study most

Prophylaxis of A/H3N2v Influenza

Studies at this site

• Safety and Immunogenicity of Three Dosage Levels of Swine Influenza Vaccine in Children Ages 3 to <9 Years, Adolescents 9 to <18 Years, Adults 18 to <65 Years and Elderly 65 Years and Older. — Completed